Thyroid dermopathy responds to teprotumumab therapy.

Crespo-Trevino R, Schiffman J, Ugradar S, Cockerham K, Douglas R, de Leon-Garza D, Tang R

DOI: 10.1530/edm-21-0201
Published: 2022 Jan 1
Container: Endocrinology, diabetes & metabolism case reports
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1530/edm-21-0201,
  title = {Thyroid dermopathy responds to teprotumumab therapy.},
  author = {Crespo-Trevino R and Schiffman J and Ugradar S and Cockerham K and Douglas R and de Leon-Garza D and Tang R},
  year = {2022},
  journal = {Endocrinology, diabetes \& metabolism case reports},
  doi = {10.1530/edm-21-0201},
  url = {https://doi.org/10.1530/edm-21-0201}
}

RIS

TY  - JOUR
TI  - Thyroid dermopathy responds to teprotumumab therapy.
AU  - Crespo-Trevino R
AU  - Schiffman J
AU  - Ugradar S
AU  - Cockerham K
AU  - Douglas R
AU  - de Leon-Garza D
AU  - Tang R
PY  - 2022
JO  - Endocrinology, diabetes & metabolism case reports
DO  - 10.1530/edm-21-0201
UR  - https://doi.org/10.1530/edm-21-0201
ER  -

APA

R, C., J, S., S, U., K, C., R, D., D, D. L., & R, T. (2022). Thyroid dermopathy responds to teprotumumab therapy.. Endocrinology, diabetes & metabolism case reports. https://doi.org/10.1530/edm-21-0201

Source records

pubmed · retrieved 2026-09-27T12:22:41.779Z